Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
Castagna L, Pagliardini T, Bramanti S, Schiano de Colella JM, Montes de Oca C, Bouabdallah R, Mariotti J, Fürst S, Granata A, De Philippis C, Harbi S, Sarina B, Legrand F, Maisano V, Weiller PJ, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Devillier R. Castagna L, et al. Among authors: montes de oca c. Bone Marrow Transplant. 2021 Apr;56(4):883-889. doi: 10.1038/s41409-020-01133-5. Epub 2020 Nov 15. Bone Marrow Transplant. 2021. PMID: 33191403 Free PMC article.
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.
De Philippis C, Legrand-Izadifar F, Bramanti S, Giordano L, Montes de Oca C, Duléry R, Bouabdallah R, Granata A, Devillier R, Mariotti J, Sarina B, Harbi S, Maisano V, Furst S, Pagliardini T, Weiller PJ, Lemarie C, Calmels B, Chabannon C, Santoro A, Mohty M, Blaise D, Castagna L. De Philippis C, et al. Among authors: montes de oca c. Blood Adv. 2020 Apr 14;4(7):1242-1249. doi: 10.1182/bloodadvances.2019001336. Blood Adv. 2020. PMID: 32227210 Free PMC article.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Montes de Oca C, Castagna L, De Philippis C, Bramanti S, Schiano JM, Pagliardini T, Collignon A, Harbi S, Mariotti J, Granata A, Maisano V, Furst S, Legrand F, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Devillier R. Montes de Oca C, et al. Biol Blood Marrow Transplant. 2020 Dec;26(12):2299-2305. doi: 10.1016/j.bbmt.2020.08.014. Epub 2020 Aug 19. Biol Blood Marrow Transplant. 2020. PMID: 32822845 Free article.
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.
Noel R, Zemmour C, Montes de Oca C, Belmecheri N, Aurran-Schleinitz T, Coso D, Lopez Almeida L, Mescam L, Vey N, Bladé JS, Slama B, Bouabdallah R, Schiano de Colella JM. Noel R, et al. Among authors: montes de oca c. Hematology. 2023 Dec;28(1):2207948. doi: 10.1080/16078454.2023.2207948. Hematology. 2023. PMID: 37133334 Clinical Trial.
A rise in T3/T4 ratio reduces the growth of prostate tumors in a murine model.
Sánchez-Tusie A, Montes de Oca C, Rodríguez-Castelán J, Delgado-González E, Ortiz Z, Álvarez L, Zarco C, Aceves C, Anguiano B. Sánchez-Tusie A, et al. Among authors: montes de oca c. J Endocrinol. 2020 Dec;247(3):225-238. doi: 10.1530/JOE-20-0310. J Endocrinol. 2020. PMID: 33112811
13 results